company background image
543332 logo

Epigral BSE:543332 Stock Report

Last Price

₹1.96k

Market Cap

₹84.8b

7D

-5.8%

1Y

118.2%

Updated

22 Dec, 2024

Data

Company Financials +

Epigral Limited

BSE:543332 Stock Report

Market Cap: ₹84.8b

543332 Stock Overview

Manufactures and sells chlor-alkali and related derivatives in India and internationally. More details

543332 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance6/6
Financial Health3/6
Dividends3/6

Rewards

Price-To-Earnings ratio (28.9x) is below the Indian market (32.4x)

Earnings are forecast to grow 19.14% per year

Earnings grew by 31.4% over the past year

Risk Analysis

Shareholders have been diluted in the past year

Volatile share price over the past 3 months compared to the Indian market

Has a high level of debt


My Notes

Capture your thoughts, links and company narrative

Epigral Limited Competitors

KAMA Holdings

BSE:532468

₹79.6b

Responsive Industries

BSE:505509

₹67.1b

GHCL

NSEI:GHCL

₹62.8b

Garware Hi-Tech Films

BSE:500655

₹116.1b

Price History & Performance

Summary of share price highs, lows and changes for Epigral
Historical stock prices
Current Share Price₹1,964.10
52 Week High₹2,408.35
52 Week Low₹900.15
Beta-0.10
1 Month Change1.01%
3 Month Change-6.38%
1 Year Change118.20%
3 Year Change158.25%
5 Year Changen/a
Change since IPO384.19%

Recent News & Updates

Recent updates

Shareholder Returns

543332IN ChemicalsIN Market
7D-5.8%-3.8%-4.3%
1Y118.2%5.4%19.1%

Return vs Industry: 543332 exceeded the Indian Chemicals industry which returned 5.4% over the past year.

Return vs Market: 543332 exceeded the Indian Market which returned 19.1% over the past year.

Price Volatility

Is 543332's price volatile compared to industry and market?
543332 volatility
543332 Average Weekly Movement7.5%
Chemicals Industry Average Movement5.8%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 543332's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: 543332's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
2007997Kaushal Soparkarwww.epigral.com

Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda, chlorine, hydrogen, and caustic potash products. It also engages in the trading of agrochemical products.

Epigral Limited Fundamentals Summary

How do Epigral's earnings and revenue compare to its market cap?
543332 fundamental statistics
Market cap₹84.82b
Earnings (TTM)₹2.94b
Revenue (TTM)₹22.73b

28.9x

P/E Ratio

3.7x

P/S Ratio

Is 543332 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
543332 income statement (TTM)
Revenue₹22.73b
Cost of Revenue₹13.19b
Gross Profit₹9.55b
Other Expenses₹6.61b
Earnings₹2.94b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)68.04
Gross Margin42.00%
Net Profit Margin12.91%
Debt/Equity Ratio63.9%

How did 543332 perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

11%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 05:51
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Epigral Limited is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullBP Wealth Management Private Limited
Meet VoraEmkay Global Financial Services Ltd.
Kameswari V. S. ChavaliFirstCall Research